- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07620847
Post-market Clinical Follow-up Study on the Performance and Safety of Coronary Artery Perfusion Cannula Used During Cardiopulmonary Bypass
1. juni 2026 opdateret af: Bıçakcılar Tıbbi Cihazlar Sanayi ve Ticaret A.Ş.
Prior to the implementation of the Medical Device Regulation (MDR), clinical evaluation of older devices was carried out by Notified Bodies (MBs) based on clinical data obtained from equivalent devices, and CE certification was granted to devices exhibiting similar characteristics.
Following the transition to the MDR, the European Union Commission's MEDDEV 2.12/2 guidance emphasizes that MBs, which issued CE certificates according to previous practices, should organize Post Marketing Clinical Follow-up (PMCF) studies to verify the performance and safety of the device throughout its lifecycle in accordance with its intended use for which it bears the CE mark.
Thus, PMCF studies are planned to demonstrate that medical devices that were previously CE marked according to previous practices are used safely for patients throughout their lifecycles.
Studieoversigt
Status
Ikke rekrutterer endnu
Betingelser
Intervention / Behandling
Undersøgelsestype
Observationel
Tilmelding (Anslået)
20
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiekontakt
- Navn: Gizem Özdemir Clinical Evaluation Secialist, Biomedical Engineer
- Telefonnummer: +90 5346137760
- E-mail: gizemozdemir@kocyasa.com
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Barn
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ingen
Prøveudtagningsmetode
Ikke-sandsynlighedsprøve
Studiebefolkning
The aim of this study is not to prove a hypothesis defined by a specific objective-numerical expectation, but rather to compile the various outcomes resulting from the use of a medical device using data obtained from all cases collected within a timeframe that is clinically appropriate and sufficient.
In this context, a minimum sample size is being established without considering an objective expectation or the Type I and Type II statistical errors accepted in the research.
The sample will be constructed by including participants such that, in a 4-option design with two types of operations and two types of cannulas, there will be at least 5 cases even for the option with the fewest patients operated on in consecutive operations.
Beskrivelse
Inclusion Criteria:
Patients who have consulted the Department of Cardiovascular Surgery and for whom the physician has decided to perform heart surgery using the cardiopulmonary bypass technique,
- Patients for whom the use of a coronary artery perfusion cannula is planned during surgery
- Patients who, prior to surgery, have provided consent in the "Cardiovascular Surgery Department Information and Consent Form, Use of Patient Data for Educational and Research Purposes" section regarding the use of their data
Exclusion Criteria:
Patients with ostial calcification and/or an ostium that is too small for the cannula tip to fit through,
- Patients known to have hypersensitivity to any of the materials used in the device components
- Patients who have difficulty understanding the study and complying with it
- Patients who may pose a conflict of interest (e.g., relatives of employees of the sponsoring company)
- Patients who have participated in any clinical trial within the past 30 days
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Presence of bleeding
Tidsramme: It will be measured during the operation up to 6 hours.
|
Primary endpoints are structured to encompass all clinical use outcomes characterizing device performance.
Evaluation items directly related to the Bıçakcılar Vent Catheter will be measured using a Likert scale with values ranging from 1 to 5.
|
It will be measured during the operation up to 6 hours.
|
|
Impact of trauma
Tidsramme: During the operation
|
It will be used a 5-likert scale.
|
During the operation
|
|
Manipulation during placement
Tidsramme: During the operation
|
It will be used a 5-likert scale.
|
During the operation
|
|
Cannula leakage
Tidsramme: During the operation
|
It will be used a 5-likert scale.
|
During the operation
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Anslået)
1. juli 2026
Primær færdiggørelse (Anslået)
1. september 2026
Studieafslutning (Anslået)
1. oktober 2026
Datoer for studieregistrering
Først indsendt
22. maj 2026
Først indsendt, der opfyldte QC-kriterier
1. juni 2026
Først opslået (Faktiske)
2. juni 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
2. juni 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
1. juni 2026
Sidst verificeret
1. juni 2026
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Andre undersøgelses-id-numre
- CIP-33004a
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Kardiopulmonal bypass
-
WANG Yan-binUkendtIskæmisk postkonditionering | Iskæmi-reperfusion (I/R) | Cardiopulmonary bypass | den mitokondrielle vejKina
-
University of CologneRekrutteringHantavirus infektioner | Hæmoragisk feber med nyresyndrom | Nephropathia Epidemica | Hantavirus Cardiopulmonary SyndromeTyskland
Kliniske forsøg med coronary artery perfusion cannula
-
University of WuerzburgDeutsche Stiftung für HerzforschungUkendtSlag | Koronar hjertesygdom | Cerebralt infarktTyskland
-
Brigham and Women's HospitalNano-X Imaging LimitedRekrutteringKoronararteriesygdomForenede Stater
-
Yonsei UniversityUkendtKoronararteriesygdom, diabetesKorea, Republikken